Product Information
MEPROBAMATE 200 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $4.5179 per EA under NDC 69097097407. Its NADAC has been published 110 times since Jul 17, 2024.
FDA first approved this application on Feb 27, 2008. Its Orange Book therapeutic-equivalence code is AA.
Strength
200 mg/1
Manufacturer
Cipla USA Inc.NDC
69097097407
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
MEPROBAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA040797FDA Approved
2/27/2008
TE Code
AA
On Market Since
6/7/2021
Price Statistics
The NADAC for MEPROBAMATE 200 MG TABLET has been published 110 times since Jul 17, 2024, and over the history we have for it it has declined 9.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.5179 per EA |
|---|---|
| All-time high | $5.0893 (Mar 11, 2026) |
| All-time low | $3.9537 (Apr 23, 2025) |
| 52-week high | $5.0893 |
| 52-week low | $3.9537 |
| Median price | $4.4354 |
| Average price | $4.4219 |
| Largest weekly change | +28.7% (Feb 18, 2026) |
| Weeks tracked | 110 |
| Tracking since | Jul 17, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MEPROBAMATE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MEPROBAMATE 200 MG TABLET, manufactured by Cipla USA Inc., is $4.5179 per EA (NDC 69097097407), effective Aug 19, 2026.
How has the price of MEPROBAMATE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for MEPROBAMATE 200 MG TABLET has declined 9.8%. It has been tracked across 110 weekly CMS publications since Jul 17, 2024.
What are the highest and lowest recorded NADAC prices for MEPROBAMATE 200 MG TABLET?
Since Jul 17, 2024, the NADAC for MEPROBAMATE 200 MG TABLET has ranged from a low of $3.9537 (Apr 23, 2025) to a high of $5.0893 (Mar 11, 2026), with a median of $4.4354 per EA.
Are there cheaper alternatives to MEPROBAMATE 200 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MEPROBAMATE 200 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures MEPROBAMATE 200 MG TABLET?
MEPROBAMATE 200 MG TABLET (NDC 69097097407) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.